Lipoprotein(a) in Coronary Artery Bypass Graft Surgery Patients: An Underappreciated Opportunity to Optimise Cardiovascular Disease Prevention.

MLA

Lan, Nick S. R., et al. “Lipoprotein(a) in Coronary Artery Bypass Graft Surgery Patients: An Underappreciated Opportunity to Optimise Cardiovascular Disease Prevention.” Heart, Lung & Circulation, vol. 30, no. 9, Sept. 2021, pp. e106–07. EBSCOhost, https://doi.org/10.1016/j.hlc.2021.03.280.

APA

Lan, N. S. R., Dwivedi, G., & Bell, D. A. (2021). Lipoprotein(a) in Coronary Artery Bypass Graft Surgery Patients: An Underappreciated Opportunity to Optimise Cardiovascular Disease Prevention. Heart, Lung & Circulation, 30(9), e106–e107. https://doi.org/10.1016/j.hlc.2021.03.280

Chicago

Lan, Nick S R, Girish Dwivedi, and Damon A Bell. 2021. “Lipoprotein(a) in Coronary Artery Bypass Graft Surgery Patients: An Underappreciated Opportunity to Optimise Cardiovascular Disease Prevention.” Heart, Lung & Circulation 30 (9): e106–7. doi:10.1016/j.hlc.2021.03.280.